U.S. Orthopedic Spine Navigation Systems Market (By Technology: Electromagnetic, Optical; By End-use: Hospitals, ASCs) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The U.S. orthopedic spine navigation systems market was surpassed at USD 0.21 billion in 2022 and is expected to hit around USD 0.68 billion by 2032, growing at a CAGR of 12.42% from 2023 to 2032.

U.S. Orthopedic Spine Navigation Systems Market Size 2023 to 2032

Key Pointers

  • Based on the technology, the industry has been classified into optical, electromagnetic, and others. The optical segment held the largest revenue share of 41% in 2022. 
  • The others segment is expected to witness the fastest CAGR of 13.22%
  • The hospital segment held the largest share of 74% in 2022. 
  • The ASCs segment is projected to grow at the fastest CAGR of 13.63% over the forecast period

Report Scope of the U.S. Orthopedic Spine Navigation Systems Market

Report Coverage Details
Market Size in 2022 USD 0.21 billion
Revenue Forecast by 2032 USD 0.68 billion
Growth rate from 2023 to 2032 CAGR of 12.42% 
Base Year 2022
Forecast Period 2023 to 2032
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Companies Covered B. Braun Melsungen AG; Stryker; Medtronic; Smith+Nephew; Johnson & Johnson Services, Inc. (DePuy Synthes); Zimmer Biomet; Kinamed, Inc.; Globus Medical; OrthAlign; Novarad Corp.

 

Spine navigation systems are advanced medical devices that help surgeons perform spinal procedures more precisely and accurately. These systems build a three-dimensional map of the patient’s anatomy using real-time imaging and computer technology, giving the surgeon the ability to see the surgery site in real-time and make more accurate incisions. Increasing incidence of lifestyle-related health conditions, growing geriatric population, and rising number of sports & road injuries are some of the major factors contributing to the market growth.

For instance, according to the UNECE, in 2019, around 2,740,000 people were injured in road traffic accidents in the U.S. Furthermore, the prevalence of spinal disorders, such as degenerative disc disease, herniated discs, and spinal stenosis, is increasing in the U.S. population, driving the demand for orthopedic spine navigation systems. As per the National Spinal Cord Injury Statistical Center (NSCSC) 2021 estimates, approximately 30% of individuals with spinal cord injuries are re-admitted to hospitals within a year of their injury, with an average hospital stay of 22 days for those requiring readmission. Furthermore, as per an article published by the University of Washington in January 2021, traumatic spinal cord injuries affect over 18,000 Americans each year.

Many of these people require assistance with daily activities like eating, grooming, and drinking water since they are unable to use their hands or arms. However, the high cost of spinal procedures, regulatory barriers, and the lack of reimbursement policies are some of the factors restraining the growth of the market. Spine navigation systems can be expensive, and some healthcare providers may not have the resources to invest in them. According to a report by the National Spinal Cord Injury Statistical Center, the first-year expenses for a Spinal Cord Injury (SCI) with paraplegia averaged USD 537,271 in 2017. For quadriplegia, the first-year expenses were up to USD 1,102,403. The subsequent yearly expenses for paraplegia averaged USD 71,172, while for quadriplegia, the expenses could reach up to USD 191,436.

These statistics highlight the substantial financial burden that SCI can impose on individuals and society. The COVID-19 pandemic has brought about substantial changes to the medical industry, resulting in considerable challenges to regular clinical operations. The surgical navigation system market has been negatively impacted due to constraints on non-essential procedures. Nevertheless, the market is expected to grow owing to the factors, such as the rising need for improved patient outcomes, which will drive the adoption of new navigation-assisted surgical technologies. For instance, in February 2021, Royal Philips launched the ClarifEye Augmented Reality Surgical Navigation for minimally invasive spine surgeries, showcasing the continued development and introduction of innovative products to support market growth.

Technology Insights

Based on the technology, the industry has been classified into optical, electromagnetic, and others. The optical segment held the largest revenue share of 41% in 2022. This is owing to the high number of minimally invasive surgeries performed and the adoption of digital surgery solutions by end-users. Optical navigation systems can track surgical instruments using cameras and reflective markers, which provide real-time and precise guidance to surgeons during procedures. They are non-invasive and do not require additional hardware, which reduces the risk of complications and infections.

These systems are also cost-effective, making them an attractive option for healthcare providers compared to other technologies, such as electromagnetic navigation systems. The others segment comprises hybrid, CT-based, and fluoroscopy-based navigation systems. The others segment is expected to witness the fastest CAGR of 13.22% in the coming years owing to the increasing volume of orthopedic surgeries, technological advancements, availability of navigation systems for orthopedic surgeries, and R&D by key market players.

End-use Insights

The end-use segment has been bifurcated into hospitals and Ambulatory Surgery Centers (ASCs). The hospital segment held the largest share of 74% in 2022. This can be attributed to the fact that many orthopedic surgeries are performed in hospital settings. In addition, an increase in preference for minimally invasive surgeries will support segment growth. Moreover, hospitals provide specialized, long-term care to patients, and treatment costs are often reimbursed, which contributes to the segment’s growth. In December 2022, SeaSpine Holdings Corp. reported the installation of its 7D FLASH Navigation System at the Inova Fairfax Hospital in the U.S. This marked the 100th installation of the company’s 7D system across the globe.

U.S. Orthopedic Spine Navigation Systems Market Share, By End-use, 2022 (%)

The ASCs segment is projected to grow at the fastest CAGR of 13.63% over the forecast period. This is due to the growing number of ASCs, the adoption of enabling technologies for orthopedic surgeries, and the cost-effectiveness of ASCs. As per March 2022 estimates by the Centers for Medicare & Medicaid Services (CMS), about 461 Medicare-Certified ASCs are present in Texas, which is higher than the 442 ASCs reported in 2021. Similarly, during the same period, the number of ASCs increased from 457 to 463 in Florida, 368 to 386 in Georgia, and 817 to 845 in California. The number of ASCs is anticipated to increase with time as these facilities enable the performing of a large number of surgeries in short periods.

U.S. Orthopedic Spine Navigation Systems Market Segmentations:

By Technology 

  • Optical
  • Electromagnetic
  • Others

By End-use 

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)

Frequently Asked Questions

The U.S. orthopedic spine navigation systems market size was reached at USD 0.21 billion in 2022 and it is projected to hit around USD 0.68 billion by 2032.

The U.S. orthopedic spine navigation systems market is growing at a compound annual growth rate (CAGR) of 12.42% from 2023 to 2032.

Key factors that are driving the U.S. orthopedic spine navigation systems market growth include rising need for solutions to reduce healthcare costs, increasing focus on patient-centric care, and strong government support.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Orthopedic Spine Navigation Systems Market 

5.1. COVID-19 Landscape: U.S. Orthopedic Spine Navigation Systems Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Orthopedic Spine Navigation Systems Market, By Technology

8.1. U.S. Orthopedic Spine Navigation Systems Market, by Technology, 2023-2032

8.1.1. Optical

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Electromagnetic

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Others

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. U.S. Orthopedic Spine Navigation Systems Market, By End-use

9.1. U.S. Orthopedic Spine Navigation Systems Market, by End-use, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Ambulatory Surgical Centers (ASCs)

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. U.S. Orthopedic Spine Navigation Systems Market, Regional Estimates and Trend Forecast

10.1. U.S.

10.1.1. Market Revenue and Forecast, by Technology (2020-2032)

10.1.2. Market Revenue and Forecast, by End-use (2020-2032)

Chapter 11. Company Profiles

11.1. B. Braun Melsungen AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Stryker

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Medtronic

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Smith+Nephew

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. LTE Scientific

11.5. Johnson & Johnson Services, Inc. (DePuy Synthes)

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Zimmer Biomet

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Kinamed, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Globus Medical

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. OrthAlign

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Novarad Corp.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers